Insights into the Functional Anatomy Behind the PREEMPT Injection Paradigm: Guidance on Achieving Optimal Outcomes

Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors’ responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?

(2016) XiChun Zhang et al.   CEPHALALGIA

Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention

(2015) Richard B. Lipton et al.   HEADACHE

Therapeutic use of botulinum toxin in migraine: mechanisms of action

(2014) Roshni Ramachandran et al.   BRITISH JOURNAL OF PHARMACOLOGY

Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: Therapeutic implications for migraine and other pains

(2014) Rami Burstein et al.   CEPHALALGIA

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program

(2013) S. K. Aurora et al.   ACTA NEUROLOGICA SCANDINAVICA

The Babinski-2 sign in hemifacial spasm

(2013) Matthias Pawlowski et al.   MOVEMENT DISORDERS

Migraine-triggered hemifacial spasm: three new cases

(2012) R Barahona-Hernando et al.   CEPHALALGIA

Espasmo hemifacial desencadenado por migraña: un caso más

(2012) C. Valencia et al.   NEUROLOGIA

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56-Week PREEMPT Clinical Program

(2011) Sheena K. Aurora et al.   HEADACHE

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial

(2010) SK Aurora et al.   CEPHALALGIA

OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial

(2010) HC Diener et al.   CEPHALALGIA

Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well-Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program

(2010) Andrew Blumenfeld et al.   HEADACHE

OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program

(2010) David W. Dodick et al.   HEADACHE